Perspective Therapeutics (CATX) EBITDA Margin (QoQ) (2010 - 2023)
Perspective Therapeutics (CATX) EBITDA Margin (QoQ) (2010 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Perspective Therapeutics | 389.10 Mn | 389.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 68,441.00 |
| Sep 30, 2023 | 20,404.00 |
| Jun 30, 2023 | -17,712.00 |
| Sep 30, 2022 | -4,352.00 |
| Jun 30, 2022 | -1,702.00 |
| Mar 31, 2022 | 1,078.00 |
| Dec 31, 2021 | 3,063.00 |
| Sep 30, 2021 | -13,836.00 |
| Jun 30, 2021 | 7,913.00 |
| Mar 31, 2021 | 755.00 |
| Dec 31, 2020 | -706.00 |
| Sep 30, 2020 | 2,222.00 |
| Jun 30, 2020 | -3,314.00 |
| Mar 31, 2020 | 2,191.00 |
| Dec 31, 2019 | -482.00 |
| Sep 30, 2019 | 2,335.00 |
| Jun 30, 2019 | 99.00 |
| Mar 31, 2019 | 1,461.00 |
| Dec 31, 2018 | 2,213.00 |
| Sep 30, 2018 | 5,066.00 |